1832 Asset Management L.P. Has $100.87 Million Position in Stryker Corporation $SYK

1832 Asset Management L.P. decreased its holdings in shares of Stryker Corporation (NYSE:SYK) by 48.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 254,963 shares of the medical technology company’s stock after selling 244,199 shares during the period. 1832 Asset Management L.P.’s holdings in Stryker were worth $100,871,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Mid American Wealth Advisory Group Inc. bought a new position in Stryker in the 2nd quarter valued at about $26,000. Elevation Point Wealth Partners LLC purchased a new stake in shares of Stryker in the second quarter worth approximately $28,000. Sachetta LLC lifted its holdings in shares of Stryker by 58.7% in the second quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 27 shares in the last quarter. Ridgewood Investments LLC boosted its position in shares of Stryker by 48.4% during the second quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock valued at $36,000 after buying an additional 30 shares during the last quarter. Finally, MTM Investment Management LLC bought a new stake in Stryker during the second quarter worth $38,000. 77.09% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on SYK. UBS Group set a $408.00 price objective on Stryker in a research note on Monday, October 13th. BTIG Research reissued a “buy” rating and set a $410.00 price target on shares of Stryker in a research report on Friday, November 14th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $435.00 price objective on shares of Stryker in a research report on Friday, November 14th. Wall Street Zen raised shares of Stryker from a “hold” rating to a “buy” rating in a research report on Saturday, October 18th. Finally, Barclays increased their price target on Stryker from $443.00 to $453.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Twelve investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $433.78.

Stryker Stock Down 0.2%

Shares of NYSE SYK opened at $365.81 on Thursday. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.85 and a quick ratio of 1.13. The stock has a market capitalization of $139.89 billion, a PE ratio of 48.07, a P/E/G ratio of 2.64 and a beta of 0.89. Stryker Corporation has a one year low of $329.16 and a one year high of $406.19. The business’s fifty day moving average price is $368.54 and its 200-day moving average price is $379.79.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, October 30th. The medical technology company reported $3.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.13 by $0.06. The business had revenue of $6.06 billion for the quarter, compared to analysts’ expectations of $6.04 billion. Stryker had a return on equity of 24.07% and a net margin of 12.07%.The firm’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same period in the previous year, the business posted $2.87 EPS. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. On average, equities research analysts anticipate that Stryker Corporation will post 13.47 EPS for the current year.

Insider Activity at Stryker

In other Stryker news, Director Ronda E. Stryker sold 276,173 shares of the stock in a transaction on Thursday, November 6th. The stock was sold at an average price of $353.28, for a total transaction of $97,566,397.44. Following the sale, the director owned 2,702,108 shares in the company, valued at $954,600,714.24. This represents a 9.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO William E. Berry, Jr. sold 1,953 shares of the firm’s stock in a transaction on Friday, November 14th. The stock was sold at an average price of $365.49, for a total value of $713,801.97. Following the completion of the transaction, the chief accounting officer directly owned 2,833 shares of the company’s stock, valued at $1,035,433.17. The trade was a 40.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 522,118 shares of company stock worth $185,381,932. 5.90% of the stock is owned by corporate insiders.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.